Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 17Neoplasms 11Venous Thrombosis 7Pulmonary Embolism 7Thrombosis 5Multiple Myeloma 4Upper Extremity Deep Vein Thrombosis 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Myeloproliferative Disorders 2Intracranial Thrombosis 2Hematologic Neoplasms 2Carcinoma, Hepatocellular 2Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thromboprophylaxis 1Thromboembolism 1Thrombocytopenia 1Thrombocythemia, Essential 1Stomach Neoplasms 1Primary Myelofibrosis 1Polycythemia Vera 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Mesenteric Ischemia 1Lymphoma 1Leukemia 1Head and Neck Neoplasms 1Glioma 1

Interventions

apixaban 2Rivaroxaban 2Central Venous Catheters 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Upper Extremity Deep Vein Thrombosis × apixaban × Clear all
NCT06603870 2025-05-30

STREAM-Line

Ottawa Hospital Research Institute

Phase 4 Recruiting
330 enrolled
Classical hematology

Neoplasms, Venous Thromboembolism, Catheter-Related Infections, Upper Extremity Deep Vein Thrombosis

NCT03100071 2021-08-03

Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Unknown
70 enrolled

Upper Extremity Deep Vein Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡